Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Simeprevir vs Sofosbuvir/Ribavirin in HCV Cirrhosis
NCT03069001Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 4 trial of simeprevir in hepatitis C (HCV), Liver cirrhosis (LC), sponsored by Ain Shams University. Started Jun 2015; status: completed.
02
Drugs
simeprevir
03
Conditions
hepatitis C (HCV)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03069001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069001.